Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
>20 year‑old venous leg ulcers show dramatic healing and pain elimination with revyve Thermoreversible revyve transforms deep tunneling wound care, delivering 90% wound volume reduction revyve rapidly normalizes chronic wound pH, driving accelerated healing in weeks WINNIPEG, Manitoba, April 16, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.